WEBULL
News
MOLN
4.650
-1.06%
-0.050
Weekly Report: what happened at MOLN last week (0202-0206)?
Weekly Report · 15h ago
Analysts Are Bullish on These Healthcare Stocks: Medtronic (MDT), Molecular Partners (MOLN)
TipRanks · 02/02 21:50
Analysts Offer Insights on Healthcare Companies: Molecular Partners (MOLN) and SI-Bone (SIBN)
TipRanks · 02/02 17:50
Molecular Partners AG Releases Data on First Patient Imaging and Dosimetry for MP0712 Radio-DARPin Therapy in SCLC
Reuters · 02/02 16:06
Molecular Partners Unveils First Human Data for DLL3-Targeting Radio-DARPin MP0712 at TWC 2026
TipRanks · 02/02 12:19
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 02/02 12:05
Molecular Partners presents first imaging, dosimetry data of MP0712
TipRanks · 02/02 10:30
Weekly Report: what happened at MOLN last week (0126-0130)?
Weekly Report · 02/02 09:57
Molecular Partners Highlights MP0712 Tumor Uptake With Limited Healthy Tissue Uptake In First Patient Data At TWC 2026, Advancing DLL3-Targeted Alpha Therapy Strategy
Benzinga · 02/02 06:41
Molecular Partners Unveils First Patient Data for DLL3-Targeted Radiotherapy MP0712 in Ongoing Clinical Trial
Reuters · 02/02 06:00
Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026
Barchart · 02/02 00:00
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Benzinga · 01/27 13:10
HC Wainwright & Co. Initiates Coverage On Molecular Partners with Buy Rating, Announces Price Target of $13
Benzinga · 01/27 11:16
Molecular Partners initiated with a Buy at H.C. Wainwright
TipRanks · 01/27 11:11
Weekly Report: what happened at MOLN last week (0119-0123)?
Weekly Report · 01/26 09:57
Molecular Partners (MOLN) Gets a Buy from LifeSci Capital
TipRanks · 01/20 13:38
Weekly Report: what happened at MOLN last week (0112-0116)?
Weekly Report · 01/19 10:01
Molecular Partners AG Unveils Advances in Targeted Cancer Therapies with Radio-DARPin Pipeline
Reuters · 01/16 08:21
Molecular Partners Launches New Clinical Trials and Maps 2026 Milestones Ahead of J.P. Morgan Healthcare Conference
TipRanks · 01/12 22:28
Weekly Report: what happened at MOLN last week (0105-0109)?
Weekly Report · 01/12 10:00
More
Webull provides a variety of real-time MOLN stock news. You can receive the latest news about MOLECULAR PARTNERS AG through multiple platforms. This information may help you make smarter investment decisions.
About MOLN
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.